atenolol has been researched along with Cancer Syndromes, Hereditary in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol has revolutionized the treatment of infantile hemangiomas, and other beta-blockers provide promising alternatives." | 2.52 | Beta-blockers for childhood vascular tumors. ( Bayart, CB; Brandling-Bennett, HA, 2015) |
| "Atenolol treatment promoted dramatic decreases in HAS scores after week 1." | 1.43 | Oral atenolol therapy for proliferating infantile hemangioma: A prospective study. ( Chen, S; Ji, Y; Jiang, X; Li, Y; Wang, Q; Xiang, B; Xu, Z; Yang, X; Zhong, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayart, CB | 1 |
| Brandling-Bennett, HA | 1 |
| Ji, Y | 1 |
| Wang, Q | 1 |
| Chen, S | 1 |
| Xiang, B | 1 |
| Xu, Z | 1 |
| Li, Y | 1 |
| Zhong, L | 1 |
| Jiang, X | 1 |
| Yang, X | 1 |
1 review available for atenolol and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Beta-blockers for childhood vascular tumors.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Prescho | 2015 |
1 other study available for atenolol and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Atenolol; Dose-Response Relationship, | 2016 |